1. Home
  2. LRE vs PASG Comparison

LRE vs PASG Comparison

Compare LRE & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRE
  • PASG
  • Stock Information
  • Founded
  • LRE 2001
  • PASG 2017
  • Country
  • LRE Japan
  • PASG United States
  • Employees
  • LRE 70
  • PASG N/A
  • Industry
  • LRE
  • PASG Biotechnology: Pharmaceutical Preparations
  • Sector
  • LRE
  • PASG Health Care
  • Exchange
  • LRE Nasdaq
  • PASG Nasdaq
  • Market Cap
  • LRE 24.4M
  • PASG 20.3M
  • IPO Year
  • LRE 2023
  • PASG 2020
  • Fundamental
  • Price
  • LRE $1.76
  • PASG $0.41
  • Analyst Decision
  • LRE
  • PASG Strong Buy
  • Analyst Count
  • LRE 0
  • PASG 3
  • Target Price
  • LRE N/A
  • PASG $7.67
  • AVG Volume (30 Days)
  • LRE 11.2K
  • PASG 376.4K
  • Earning Date
  • LRE 01-01-0001
  • PASG 08-07-2025
  • Dividend Yield
  • LRE N/A
  • PASG N/A
  • EPS Growth
  • LRE N/A
  • PASG N/A
  • EPS
  • LRE N/A
  • PASG N/A
  • Revenue
  • LRE $110,330,328.00
  • PASG N/A
  • Revenue This Year
  • LRE N/A
  • PASG N/A
  • Revenue Next Year
  • LRE N/A
  • PASG N/A
  • P/E Ratio
  • LRE N/A
  • PASG N/A
  • Revenue Growth
  • LRE 3.92
  • PASG N/A
  • 52 Week Low
  • LRE $1.10
  • PASG $0.26
  • 52 Week High
  • LRE $2.49
  • PASG $1.33
  • Technical
  • Relative Strength Index (RSI)
  • LRE 54.52
  • PASG 50.18
  • Support Level
  • LRE $1.71
  • PASG $0.40
  • Resistance Level
  • LRE $1.78
  • PASG $0.49
  • Average True Range (ATR)
  • LRE 0.08
  • PASG 0.05
  • MACD
  • LRE -0.01
  • PASG 0.00
  • Stochastic Oscillator
  • LRE 28.78
  • PASG 45.32

About LRE Lead Real Estate Co. Ltd

Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.

About PASG Passage Bio Inc.

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.

Share on Social Networks: